Logo image of CHSCN

CHS INC - CHSINC 7.1 PERP (CHSCN) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:CHSCN - US12542R5063

25.439 USD
+0.17 (+0.67%)
Last: 1/23/2026, 2:49:56 PM
Fundamental Rating

3

Taking everything into account, CHSCN scores 3 out of 10 in our fundamental rating. CHSCN was compared to 87 industry peers in the Food Products industry. There are concerns on the financial health of CHSCN while its profitability can be described as average. CHSCN has a expensive valuation and it also scores bad on growth. CHSCN also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year CHSCN had a positive cash flow from operations.
  • In the past 5 years CHSCN has always been profitable.
  • In the past 5 years CHSCN always reported a positive cash flow from operatings.
CHSCN Yearly Net Income VS EBIT VS OCF VS FCFCHSCN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

1.2 Ratios

  • CHSCN's Return On Assets of 3.17% is fine compared to the rest of the industry. CHSCN outperforms 60.92% of its industry peers.
  • With a Return On Equity value of 5.40%, CHSCN perfoms like the industry average, outperforming 57.47% of the companies in the same industry.
  • CHSCN has a Return On Invested Capital (0.49%) which is in line with its industry peers.
  • CHSCN had an Average Return On Invested Capital over the past 3 years of 3.89%. This is significantly below the industry average of 27.79%.
Industry RankSector Rank
ROA 3.17%
ROE 5.4%
ROIC 0.49%
ROA(3y)6.36%
ROA(5y)6.23%
ROE(3y)11.28%
ROE(5y)11.55%
ROIC(3y)3.89%
ROIC(5y)4.02%
CHSCN Yearly ROA, ROE, ROICCHSCN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • CHSCN has a Profit Margin (1.69%) which is in line with its industry peers.
  • CHSCN's Profit Margin has improved in the last couple of years.
  • CHSCN has a worse Operating Margin (0.26%) than 60.92% of its industry peers.
  • CHSCN's Operating Margin has declined in the last couple of years.
  • With a Gross Margin value of 3.21%, CHSCN is not doing good in the industry: 83.91% of the companies in the same industry are doing better.
  • In the last couple of years the Gross Margin of CHSCN has remained more or less at the same level.
Industry RankSector Rank
OM 0.26%
PM (TTM) 1.69%
GM 3.21%
OM growth 3Y-52.33%
OM growth 5Y-23.53%
PM growth 3Y-21.71%
PM growth 5Y2.56%
GM growth 3Y-10.36%
GM growth 5Y-1.5%
CHSCN Yearly Profit, Operating, Gross MarginsCHSCN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4 5

3

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CHSCN is destroying value.
  • CHSCN has a worse debt/assets ratio than last year.
CHSCN Yearly Shares OutstandingCHSCN Yearly Shares OutstandingYearly Shares Outstanding 2018 2M 4M 6M 8M 10M
CHSCN Yearly Total Debt VS Total AssetsCHSCN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • CHSCN has an Altman-Z score of 2.32. This is not the best score and indicates that CHSCN is in the grey zone with still only limited risk for bankruptcy at the moment.
  • CHSCN has a Altman-Z score of 2.32. This is comparable to the rest of the industry: CHSCN outperforms 50.57% of its industry peers.
  • CHSCN has a Debt/Equity ratio of 0.26. This is a healthy value indicating a solid balance between debt and equity.
  • With a decent Debt to Equity ratio value of 0.26, CHSCN is doing good in the industry, outperforming 65.52% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Altman-Z 2.32
ROIC/WACC0.09
WACC5.46%
CHSCN Yearly LT Debt VS Equity VS FCFCHSCN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B 8B 10B

2.3 Liquidity

  • CHSCN has a Current Ratio of 1.53. This is a normal value and indicates that CHSCN is financially healthy and should not expect problems in meeting its short term obligations.
  • CHSCN has a Current ratio (1.53) which is in line with its industry peers.
  • CHSCN has a Quick Ratio of 1.53. This is a bad value and indicates that CHSCN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CHSCN has a Quick ratio of 0.91. This is comparable to the rest of the industry: CHSCN outperforms 52.87% of its industry peers.
Industry RankSector Rank
Current Ratio 1.53
Quick Ratio 0.91
CHSCN Yearly Current Assets VS Current LiabilitesCHSCN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

1

3. Growth

3.1 Past

  • The Revenue has decreased by -9.68% in the past year.
  • Measured over the past years, CHSCN shows a small growth in Revenue. The Revenue has been growing by 4.54% on average per year.
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-9.68%
Revenue growth 3Y-9.47%
Revenue growth 5Y4.54%
Sales Q2Q%-6.19%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CHSCN Yearly Revenue VS EstimatesCHSCN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

1

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
CHSCN Price Earnings VS Forward Price EarningsCHSCN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CHSCN indicates a rather cheap valuation: CHSCN is cheaper than 96.55% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 2.45
CHSCN Per share dataCHSCN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 500 1K 1.5K 2K 2.5K

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

8

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 6.78%, CHSCN is a good candidate for dividend investing.
  • CHSCN's Dividend Yield is rather good when compared to the industry average which is at 2.28. CHSCN pays more dividend than 90.80% of the companies in the same industry.
  • CHSCN's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 6.78%

5.2 History

  • CHSCN has paid a dividend for at least 10 years, which is a reliable track record.
  • CHSCN has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years10
CHSCN Yearly Dividends per shareCHSCN Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • 28.20% of the earnings are spent on dividend by CHSCN. This is a low number and sustainable payout ratio.
DP28.2%
EPS Next 2YN/A
EPS Next 3YN/A
CHSCN Yearly Income VS Free CF VS DividendCHSCN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B 2.5B
CHSCN Dividend Payout.CHSCN Dividend Payout, showing the Payout Ratio.CHSCN Dividend Payout.PayoutRetained Earnings

CHS INC - CHSINC 7.1 PERP / CHSCN FAQ

What is the ChartMill fundamental rating of CHS INC - CHSINC 7.1 PERP (CHSCN) stock?

ChartMill assigns a fundamental rating of 3 / 10 to CHSCN.


What is the valuation status for CHSCN stock?

ChartMill assigns a valuation rating of 1 / 10 to CHS INC - CHSINC 7.1 PERP (CHSCN). This can be considered as Overvalued.


What is the profitability of CHSCN stock?

CHS INC - CHSINC 7.1 PERP (CHSCN) has a profitability rating of 4 / 10.


Can you provide the financial health for CHSCN stock?

The financial health rating of CHS INC - CHSINC 7.1 PERP (CHSCN) is 3 / 10.